| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | REVIEWS IN MEDICAL VIROLOGY LetPub Score 7.3
50 ratings
Rate
Reputation 8.8 Influence 6.2 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | REV MED VIROL | ||||||||||||||||||||
| ISSN | 1052-9276 | ||||||||||||||||||||
| E-ISSN | 1099-1654 | ||||||||||||||||||||
| h-index | 84 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 1.10%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1654 | ||||||||||||||||||||
| 在線稿件提交 | http://mc.manuscriptcentral.com/rmv | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | John Wiley and Sons Ltd | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||||||
| 發行頻率 | 四半期刊行 | ||||||||||||||||||||
| 創刊年 | 1991 | ||||||||||||||||||||
| 每年文章數 | 74每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 13.01% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1052-9276%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [REVIEWS IN MEDICAL VIROLOGY] 的評論 | 撰寫評論 |
| 作者: 骨架炎彬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2024-03-05 22:29:37 評論於 Teacher Jiang? Guess who I am  (0) 讚！ | 骨架炎彬  |
| 作者: Caesar Hart 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2022-11-17 10:34:09 評論於 Hello, may I ask how much is the layout fee? (0) 讚！ | Caesar Hart |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 18:46:36 評論於 The list of SCI Division of Chinese Academy of Sciences is still a necessary reference directory for the research performance rewards and title review of many universities and research institutions in China (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 21:36:00 評論於 Do we need to consider the categories when selecting articles for publication? (0) 讚！ | 陶宜三岁啦 |
| 作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 14:26:29 評論於 How are SCI Journals Categorized? (0) 讚！ | 破戒阳平 |
| 作者: 江南白桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-09-10 08:55:41 評論於 Fortunately, the article was finally accepted and is awaiting publication (0) 讚！ | 江南白桃 |
| 作者: 江南白桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-06-16 18:11:42 評論於 Review Speed: 6.0 | Submission success rate: 25.0 Experience sharing: Huge pit, garbage, submitted in February, reminded 4 or 5 times in between, was told there were two review comments, still waiting for one more, waited another month, now no response after more reminders. Now it's neither withdrawing nor waiting, a good article has been wasted. Now I don't know what to do. Mentally exhausted (0) 讚！ | 江南白桃 |
| 作者: 缠丝醉蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-02-02 19:57:51 評論於 Why are there so few comments? Did nobody vote? The official website didn't mention how much the layout fee is (0) 讚！ | 缠丝醉蝶 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-16 19:33:10 評論於 Passing the 5 point mark is worth celebrating. Next year, we aim to reach even greater heights by passing the 6 point mark (0) 讚！ | 凌霄高洁 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2013-06-30 17:04:01 評論於 2011(7.2); 2012(7.615 (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
